Skip to main content
. Author manuscript; available in PMC: 2012 Oct 19.
Published in final edited form as: Biochem Biophys Res Commun. 2012 Jul 20;425(2):177–181. doi: 10.1016/j.bbrc.2012.07.062

Figure 3.

Figure 3

Activated p38 and Akt signaling pathways are blocked by the treatment with p38 and Akt inhibitors when administered singly or in combination. (A) Immunofluorescence staining showing expression of phosphorylated p38, mTOR and Akt. (B) Western blot analysis showing effects of single and combined treatments with p38 and Akt inhibitors on the expression of total and phosphorylated p38, Akt and MAPKAP-2.